Polarean Imaging (POLX) Price & Analysis

Compare

11 Followers

POLX Stock Chart & Stats

Day’s Range― - ―

52-Week Range0.55p - 1.70p

Previous CloseN/A

Volume3.22M

Average Volume (3M)4.15M

Market Cap

£6.94M

Enterprise Value6.72M

Total Cash (Recent Filing)£12.11M

Total Debt (Recent Filing)£503.79K

Price to Earnings (P/E)―

Beta1.57

Next Earnings

Jun 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding1,207,032,800

10 Day Avg. Volume7,920,910

30 Day Avg. Volume4,152,526

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

£2.23

Price Target Upside284.44% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Market ExpansionPolarean has signed a distribution agreement with Sumtage Enterprise for the distribution of Polarean’s Xenon MRI platform in Taiwan, marking Polarean's entry into the Taiwanese market.

Strategic CollaborationPolarean has signed a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the US.

Bears Say

Commercial Roll-OutA potential commercial roll-out in Taiwan seems unlikely until the second half of 2026.

Polarean Imaging News

Polarean Imaging Sells Xenon MRI System to NIH Clinical Center

The latest announcement is out from Polarean Imaging ( ($GB:POLX) ). Polarean Imaging has announced the sale of...

8h ago

Polarean Imaging Faces Market Challenges but Expands Strategic Partnerships

Polarean Imaging ( ($GB:POLX) ) just unveiled an announcement. Polarean Imaging has reported its interim results for the...

13h ago

Polarean Imaging to Announce Half-Year Results and Host Investor Presentation

Polarean Imaging ( ($GB:POLX) ) has issued an announcement. Polarean Imaging PLC, a leader in advanced MRI technology...

10d ago

Polarean Imaging Seeks FDA Approval for Expanded Use of XENOVIEW®

The latest announcement is out from Polarean Imaging ( ($GB:POLX) ). Polarean Imaging plc has submitted a new...

1M ago

Polarean Imaging Partners with Ascend Imaging to Boost US Market Growth

Polarean Imaging ( ($GB:POLX) ) has provided an announcement. Polarean Imaging has entered into a Representative Agreement with...

3M ago

Polarean Imaging announces FDA expansion of XENOVIEW indication

Polarean Imaging (PLLWF) announces that the US Food and Drug Administration has approved the Company’s Supplemental New Drug...

4M ago

Polarean Imaging Expands XENOVIEW® Indication to Younger Patients

Polarean Imaging ( ($GB:POLX) ) just unveiled an announcement. Polarean Imaging Plc announced that the FDA has approved...

4M ago

Polarean’s Dr. Bastiaan Driehuys Honored for Xenon MRI Innovations

Polarean Imaging ( ($GB:POLX) ) has shared an announcement. Polarean Imaging announced that Dr. Bastiaan Driehuys, its Chief...

4M ago

Polarean Imaging says Xenon MRI to be featured prominently at ATS 2025

Polarean Imaging (PLLWF) will be featured at the American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit, taking place...

4M ago

Polarean Imaging’s Xenon MRI to Take Center Stage at ATS 2025

Polarean Imaging ( ($GB:POLX) ) just unveiled an announcement. Polarean Imaging plc’s Xenon MRI technology will be prominently...

4M ago

Polarean and Philips Collaborate to Advance Pediatric Lung MRI Technology

Polarean Imaging ( ($GB:POLX) ) has issued an update. Polarean Imaging has announced a continued collaboration with Philips...

4M ago

Polarean Imaging Reports Strong Revenue Growth and Strategic Expansions

The latest announcement is out from Polarean Imaging ( ($GB:POLX) ). Polarean Imaging Plc reported a significant increase...

5M ago

Polarean Imaging, SimonMed collaborate to advance lung imaging

Polarean Imaging (PLLWF) announces a strategic collaboration with SimonMed Imaging to expand access to Polarean’s Xenon MRI platform....

8M ago

Polarean Imaging announces FDA clearance of XENOVIEW 3T chest coil

Polarean Imaging (PLLWF) has received 510(k) clearance from the U.S. Food and Drug Administration for the Company’s specialized...

10M ago

GEHC

POLX FAQ

What was Polarean Imaging Plc’s price range in the past 12 months?

Polarean Imaging Plc lowest share price was 0.55p and its highest was 1.70p in the past 12 months.

What is Polarean Imaging Plc’s market cap?

Polarean Imaging Plc’s market cap is £6.94M.

When is Polarean Imaging Plc’s upcoming earnings report date?

Polarean Imaging Plc’s upcoming earnings report date is Jun 18, 2026 which is in 266 days.

How were Polarean Imaging Plc’s earnings last quarter?

Polarean Imaging Plc released its earnings results on Sep 25, 2025. The company reported -0.003p earnings per share for the quarter, missing the consensus estimate of N/A by -0.003p.

Is Polarean Imaging Plc overvalued?

According to Wall Street analysts Polarean Imaging Plc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Polarean Imaging Plc pay dividends?

Polarean Imaging Plc does not currently pay dividends.

What is Polarean Imaging Plc’s EPS estimate?

Polarean Imaging Plc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Polarean Imaging Plc have?

Polarean Imaging Plc has 1,207,032,800 shares outstanding.

What happened to Polarean Imaging Plc’s price movement after its last earnings report?

Polarean Imaging Plc reported an EPS of -0.003p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.756%.

Which hedge fund is a major shareholder of Polarean Imaging Plc?

Currently, no hedge funds are holding shares in GB:POLX

Company Description

Polarean Imaging Plc

Polarean Imaging plc is a medical imaging technology company focused on developing and commercializing advanced imaging solutions for use in lung diseases. The company specializes in the development of hyperpolarized gas MRI technology, which enhances the visibility of lung function and structure in magnetic resonance imaging, offering a non-invasive method for assessing respiratory conditions. Its core product, the Polarean System, aims to improve the diagnosis and monitoring of diseases such as asthma and chronic obstructive pulmonary disease (COPD). Polarean operates within the healthcare sector, specifically in medical imaging and diagnostics.

Polarean Imaging (POLX) Earnings & Revenues

Historic Earnings Reports

POLX Stock 12 Month Forecast

Average Price Target

2.23p

▲(284.44% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"78":"78p","-1":"-1p","18.75":"18.75p","38.5":"38.5p","58.25":"58.3p"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.716226,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">3.72p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.2297356,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">2.23p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.7432452,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">0.74p</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,18.75,38.5,58.25,78],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2021","6":"Dec<br/>2022","9":"Jan<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.05,1.2550943076923078,1.4601886153846153,1.665282923076923,1.8703772307692308,2.0754715384615388,2.280565846153846,2.485660153846154,2.6907544615384618,2.8958487692307693,3.100943076923077,3.3060373846153848,3.511131692307692,{"y":3.716226,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.05,1.1407488923076923,1.2314977846153847,1.322246676923077,1.4129955692307692,1.5037444615384616,1.5944933538461539,1.6852422461538463,1.7759911384615386,1.8667400307692308,1.9574889230769232,2.0482378153846152,2.1389867076923075,{"y":2.2297356,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.05,1.026403476923077,1.002806953846154,0.9792104307692309,0.9556139076923077,0.9320173846153846,0.9084208615384616,0.8848243384615385,0.8612278153846155,0.8376312923076923,0.8140347692307692,0.7904382461538462,0.7668417230769231,{"y":0.7432452,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":77.622,"date":1609459200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":77.622,"date":1612137600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":77.622,"date":1614556800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":77.622,"date":1617235200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":77.622,"date":1619827200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":77.622,"date":1619827200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.914,"date":1669852800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.113,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.6,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.325,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.25,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.4,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.05,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >